Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Expanding the roles of community health workers to sustain programmes during malaria elimination: a meeting report on operational research in Southeast Asia
Dysoley L. et al, (2024), Malaria Journal, 23
Comparing the roles of community health workers for malaria control and elimination in Cambodia and Tanzania
Adhikari B. et al, (2023), BMJ Global Health, 8, e013593 - e013593
Ethical and cultural implications for conducting verbal autopsies in South and Southeast Asia: a qualitative study.
Htun NSN. et al, (2023), BMJ global health, 8
Expanding the role of village malaria workers in Cambodia: Implementation and evaluation of four health education packages
Betrian M. et al, (2023), PLOS ONE, 18, e0283405 - e0283405
Activity of Ivermectin and Its Metabolites against Asexual Blood Stage Plasmodium falciparum and Its Interactions with Antimalarial Drugs.
Yipsirimetee A. et al, (2023), Antimicrobial agents and chemotherapy, 67
The feasibility of novel point-of-care diagnostics for febrile illnesses at health centres in Southeast Asia: a mixed-methods study
Adella FJ. et al, (2023), Transactions of The Royal Society of Tropical Medicine and Hygiene
Community engagement among forest goers in a malaria prophylaxis trial: implementation challenges and implications
Conradis-Jansen F. et al, (2023), Malaria Journal, 22
Adapting international clinical trials during COVID-19 and beyond
Thriemer K. et al, (2023), Clinical Trials, 20, 237 - 241
Glucose-6-Phosphate Dehydrogenase (G6PD) Measurement Using Biosensors by Community-Based Village Malaria Workers and Hospital Laboratory Staff in Cambodia: A Quantitative Study.
Adhikari B. et al, (2023), Pathogens (Basel, Switzerland), 12
Village malaria workers for the community-based management of vivax malaria
Adhikari B. et al, (2023), The Lancet Regional Health - Southeast Asia, 9, 100128 - 100128
Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial
Tripura R. et al, (2023), The Lancet Infectious Diseases, 23, 81 - 90
Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries
Srisutham S. et al, (2022), PLOS ONE, 17, e0278928 - e0278928
Field evaluation of the diagnostic performance of EasyScan GO: a digital malaria microscopy device based on machine-learning
Das D. et al, (2022), Malaria Journal, 21
Glucose 6 Phosphate Dehydrogenase (G6PD) quantitation using biosensors at the point of first contact: a mixed method study in Cambodia
Adhikari B. et al, (2022), Malaria Journal, 21
Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
van der Pluijm RW. et al, (2022), The Lancet Infectious Diseases, 22, 765 - 766
Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
Peto TJ. et al, (2022), The Lancet Infectious Diseases, 22, 867 - 878
Optimizing bulk segregant analysis of drug resistance using Plasmodium falciparum genetic crosses conducted in humanized mice
Brenneman KV. et al, (2022), iScience, 25, 104095 - 104095
Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response
Zhu L. et al, (2022), Communications Biology, 5
Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project
Chandna A. et al, (2022), Wellcome Open Research, 6, 64 - 64
Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project
Chandna A. et al, (2022), Wellcome Open Research, 6, 64 - 64